← Back to Screener
Illumina Inc (ILMN)
Price$164.40
Value ScoreD
Growth ScoreD
Momentum ScoreA
Favorite Metrics
Price vs S&P 500 (26W)20.71%
Price vs S&P 500 (4W)15.05%
VGM Score54.11
Market Capitalization$24.84B
P/E Ratio (Annual)29.22x
All Metrics
P/CF (Annual)23.02x
Book Value / Share (Quarterly)$17.61
P/TBV (Annual)8.18x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-1.78%
Cash Flow / Share (Quarterly)$6.41
Price vs S&P 500 (YTD)13.31%
Gross Margin (TTM)66.72%
Net Profit Margin (TTM)19.42%
EPS (TTM)$5.52
10-Day Avg Trading Volume1.69M
EPS Excl Extra (TTM)$5.52
Revenue Growth (5Y)6.04%
EPS (Annual)$5.45
ROI (Annual)18.04%
Gross Margin (Annual)66.08%
Net Profit Margin (5Y Avg)-22.68%
Cash / Share (Quarterly)$7.60
P/E Basic Excl Extra (TTM)29.12x
Revenue Growth QoQ (YoY)4.80%
EPS Growth (5Y)4.22%
P/E Normalized (Annual)29.22x
ROA (Last FY)12.79%
Revenue Growth TTM (YoY)1.29%
EBITD / Share (TTM)$6.78
ROE (5Y Avg)-20.04%
Operating Margin (TTM)19.26%
Cash Flow / Share (Annual)$6.08
P/B Ratio9.28x
P/B Ratio (Quarterly)6.86x
Net Income / Employee (Annual)$98,800
EV / Revenue (TTM)5.86x
Net Interest Coverage (TTM)-2.28x
ROA (TTM)13.40%
EPS Growth QoQ (YoY)5.61%
EV / EBITDA (TTM)24.56x
EPS Incl Extra (Annual)$5.45
Current Ratio (Annual)2.08x
Quick Ratio (Quarterly)1.22x
3-Month Avg Trading Volume1.86M
52-Week Price Return93.36%
EV / Free Cash Flow (Annual)27.64x
P/E Incl Extra (TTM)29.12x
Revenue / Employee (TTM)$510,800
Tangible BV / Share (Quarterly)$14.78
P/S Ratio (Annual)5.72x
Asset Turnover (Annual)0.65x
52-Week High$165.37
Operating Margin (5Y Avg)-23.62%
EPS Excl Extra (Annual)$5.45
CapEx CAGR (5Y)-4.77%
Tangible BV CAGR (5Y)-11.20%
26-Week Price Return36.64%
Quick Ratio (Annual)1.58x
13-Week Price Return27.91%
Total Debt / Equity (Annual)0.73x
Current Ratio (Quarterly)1.75x
Enterprise Value$25.74B
Revenue / Share Growth (5Y)4.93%
Asset Turnover (TTM)0.69x
Book Value / Share Growth (5Y)-11.15%
Revenue / Employee (Annual)$505,000
Inventory Turnover (Annual)2.65x
Pretax Margin (Annual)25.01%
Cash / Share (Annual)$10.67
3-Month Return Std Dev41.24%
Gross Margin (5Y Avg)65.39%
Net Income / Employee (TTM)$99,200
EBITDA CAGR (5Y)6.53%
EBITDA Interim CAGR (5Y)2.13%
ROE (Last FY)31.22%
Net Interest Coverage (Annual)22.64x
EPS Basic Excl Extra (Annual)$5.45
P/FCF (TTM)25.50x
Receivables Turnover (TTM)5.96x
EV / Free Cash Flow (TTM)26.42x
Total Debt / Equity (Quarterly)0.74x
EPS Incl Extra (TTM)$5.52
Receivables Turnover (Annual)5.34x
ROI (TTM)18.96%
P/S Ratio (TTM)5.65x
Pretax Margin (5Y Avg)-20.36%
Revenue / Share (Annual)$27.84
Tangible BV / Share (Annual)$16.42
Forward P/E29.61x
Free OCF CAGR (5Y)0.88%
Price vs S&P 500 (52W)65.15%
P/E Ratio (TTM)29.12x
Year-to-Date Return24.25%
5-Day Price Return12.85%
EPS Normalized (Annual)$5.45
ROA (5Y Avg)-9.81%
Net Profit Margin (Annual)19.57%
Month-to-Date Return28.58%
Cash Flow / Share (TTM)$-4.41
EBITD / Share (Annual)$6.47
Operating Margin (Annual)18.58%
LT Debt / Equity (Annual)0.55x
P/CF (TTM)22.02x
ROI (5Y Avg)-13.42%
P/E Excl Extra (TTM)29.12x
LT Debt / Equity (Quarterly)0.56x
EPS Basic Excl Extra (TTM)$5.52
P/TBV (Quarterly)8.17x
P/B Ratio (Annual)7.55x
Inventory Turnover (TTM)2.55x
Pretax Margin (TTM)24.13%
Book Value / Share (Annual)$17.80
Price vs S&P 500 (13W)18.17%
Net Margin Growth (5Y)-0.68%
Beta1.49x
P/FCF (Annual)26.68x
Revenue / Share (TTM)$28.53
ROE (TTM)33.99%
52-Week Low$78.79
vGradeD
gGradeD
mGradeA
vgmGradeC
Show chart for
Earnings Surprise History
Q1 261.15est. 1.08
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
3.62
3.68
3.68
3.68
Industry Peers — Lab Analytical Instruments(24)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ILMNIllumina Inc | D | D | A | $164.40 |
| AAgilent Technologies Inc. | C | C | B | $135.98 |
| WATWaters Corp | D | C | B | $378.16 |
| MTDMettler-Toledo International | D | C | C | $1183.57 |
| RVTYRevvity, Inc. | C | D | B | $100.52 |
| BRKRBruker Corporation | D | D | A | $58.44 |
| BIOBio-Rad Laboratories, Inc.Class A | C | F | B | $305.46 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | F | B | $304.15 |
| AVTRAvantor, Inc. | B | D | C | $9.19 |
| TXG10x Genomics, Inc. Class A Common Stock | D | C | A | $29.59 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | — | B | $20.51 |
About
Illumina is a leading provider of genetic analysis tools and services for life science and clinical applications. The company derives over 90% of revenue from sequencing instruments, consumables, and related services, offering both high-throughput whole genome sequencing and targeted solutions for viral and cancer detection. Illumina also operates a microarray business (9% of 2024 revenue) serving consumer genomics and agricultural markets with more cost-effective genetic screening options.